Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00JSG
|
||||
| Former ID |
DIB010689
|
||||
| Drug Name |
Fluoratec
|
||||
| Synonyms |
Technepine; DAT imaging agent, Alseres; DAT imaging agent, Boston life Sciences; DAT imaging agent, Harvard University; Dopamine transporter imaging agent, Alseres; Dopamine transporter imaging agent, Boston life Sciences; O-1505; O-1505T; O-1506; O-1730; O-1783; O-1794; O-861T; Dopamine transporter imaging agent, Harvard/MIT/Organix; 99mTc-O-1505; 99mTc-O-1505T
|
||||
| Indication | Attention deficit hyperactivity disorder [ICD9: 314; ICD10:F90] | Terminated | [547430] | ||
| Company |
Harvard University
|
||||
| Canonical SMILES |
N(CC(=O)[N-]CC[S-])(CC[S-])CCCN1[C@H]2[C@H]([C@@H](C[C@<br/>@H]1CC2)c1ccc(cc1)F)C(=O)CC.[99Tc+3]=O
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent dopamine transporter | Target Info | Modulator | [534375] | |
| Pathway Interaction Database | Alpha-synuclein signaling | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.